| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
283 |
255 |
$204K |
| 92134 |
|
7,783 |
7,075 |
$195K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
3,445 |
3,178 |
$177K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,424 |
1,348 |
$77K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,775 |
1,669 |
$61K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,124 |
1,060 |
$35K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
277 |
271 |
$28K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
379 |
361 |
$25K |
| 92235 |
|
127 |
111 |
$7K |
| 92250 |
|
139 |
124 |
$5K |
| 99072 |
|
168 |
156 |
$445.24 |
| J7999 |
Compounded drug, not otherwise classified |
28 |
27 |
$282.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
169 |
166 |
$0.00 |
| 5010F |
|
96 |
91 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
25 |
24 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
26 |
25 |
$0.00 |
| 4177F |
|
12 |
12 |
$0.00 |